Page last updated: 2024-09-03

nitroflurbiprofen and Muscular Dystrophy, Duchenne

nitroflurbiprofen has been researched along with Muscular Dystrophy, Duchenne in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Nardi, C; Monopoli, A; Ongini, E; Thomas, GD; Victor, RG; Ye, J	1
Bottinelli, R; Brunelli, S; Clementi, E; Cossu, G; Covarello, D; D'Antona, G; Galvez, BG; Innocenzi, A; Monopoli, A; Ongini, E; Perrotta, C; Sanvito, F; Sciorati, C	1

Other Studies

2 other study(ies) available for nitroflurbiprofen and Muscular Dystrophy, Duchenne

Article	Year
Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy. PloS one, 2012, Volume: 7, Issue:11 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Disease Models, Animal; Feeding Behavior; Flurbiprofen; Hemodynamics; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscles; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Norepinephrine; Time Factors; Vasoconstriction; Weight Gain	2012
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proceedings of the National Academy of Sciences of the United States of America, 2007, Jan-02, Volume: 104, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Combined Modality Therapy; Creatine Kinase; Flurbiprofen; Mice; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Prednisolone; Regeneration; Sarcoglycans; Stem Cell Transplantation	2007

Article

Year

Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.

PloS one, 2012, Volume: 7, Issue:11

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Disease Models, Animal; Feeding Behavior; Flurbiprofen; Hemodynamics; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscles; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Norepinephrine; Time Factors; Vasoconstriction; Weight Gain

2012

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Jan-02, Volume: 104, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Combined Modality Therapy; Creatine Kinase; Flurbiprofen; Mice; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Prednisolone; Regeneration; Sarcoglycans; Stem Cell Transplantation

2007